Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

When is data “practice-changing”? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With the world’s largest cancer conference just concluded, we explain the most important data presented at the meeting, including a blockbuster clinical trial that promises to change the treatment of advanced breast cancer. We also discuss an FDA controversy in the making, a pair of new Covid-19 vaccines, and the frustrating process of finding new treatments for depression.

For more on what we cover, here’s the news from the American Society of Clinical Oncology meeting; here’s the latest from Novavax; here’s more on Moderna’s new Covid-19 vaccine; here’s the news on Praxis Precision Medicines’ depression treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].